Epidemiology
Research conducted at Erasmus Medical Center has provided new information about epidemiology
Published in Telemedicine Business Week, February 14th, 2007
Investigators publish new data in the report "Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries." According to a study from Rotterdam, Netherlands, "To evaluate long-term outcomes after drug-eluting stents (DES) implantation in small coronary vessels. Sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have been reported to improve both the angiographic and clinical outcomes compared with bare metal stents even in 'real world' settings. Currently, no data is available on long-term outcomes after DES implantation in small vessels."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Alcoholism
Findings from National Institute of Mental Health advance knowledge in alcoholism - Alzheimer Disease
Nuclear magnetic resonance technique reveals molecular details of Alzheimer - Amyloidosis Immunology
New amyloidosis immunology findings from Mayo Clinic, Division of Anatomic Pathology described - Analgesics
New analgesics research has been reported by scientists at Ain Shams University - Andrology
Data on andrology discussed by researchers at Wuhan University - Anesthesia
Studies in the area of anesthesia reported from Orebro University - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
